Investors Research Corp - ADC THERAPEUTICS SA ownership

ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 56 filers reported holding ADC THERAPEUTICS SA in Q3 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.

Quarter-by-quarter ownership
Investors Research Corp ownership history of ADC THERAPEUTICS SA
ValueSharesWeighting
Q4 2022$77200.0%0.00%
Q3 2022$0200.0%0.00%
Q2 2022$0200.0%0.00%
Q1 2022$0200.0%0.00%
Q4 2021$0
-100.0%
200.0%0.00%
Q3 2021$1,000200.0%0.00%
Q2 2021$0200.0%0.00%
Q1 2021$0200.00%
Other shareholders
ADC THERAPEUTICS SA shareholders Q3 2021
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 1,680,149$33,939,0009.12%
Redmile Group, LLC 7,451,029$150,511,0003.42%
Grosvenor Holdings, L.L.C. 1,517,212$30,648,0003.17%
Indie Asset Partners, LLC 96,582$1,951,0001.42%
MPM BioImpact LLC 337,396$6,815,0001.24%
Eventide Asset Management 1,975,000$39,895,0000.51%
HHLR ADVISORS, LTD. 500,000$10,100,0000.16%
Virtus ETF Advisers LLC 19,193$388,0000.15%
CNA FINANCIAL CORP 15,245$308,0000.08%
Employees Retirement System of Texas 278,000$5,616,0000.06%
View complete list of ADC THERAPEUTICS SA shareholders